IBT Laboratories launches two new assays for immune deficiency
The Mannan Binding Lectin (MBL) pathway is one of the most important components of the innate immune system. IBT has said that it has developed a unique and
Boehringer Ingelheim has signed a research collaboration agreement with Combotope Therapeutics to advance tumour-selective antibody therapies targeting cancer.